Acute Coronary Syndrome

Published Online: Monday, March 25, 2013
Follow Pharmacy_Times:
In this podcast from the University of Wisconsin School of Medicine and Public Health, Marc Bellazzini, MD, discusses the presentation and management of acute coronary syndrome with Giorgio Gimelli, MD, FACC, associate professor of medicine in the Division of Cardiovascular Medicine at the University of Wisconsin School of Medicine and Public Health. To download the podcast, click here.
Related Articles
Digoxin is associated with a 71% increased risk of death and a 63% higher risk of hospitalization among adults diagnosed with atrial fibrillation who have no evidence of heart failure.
A Merck study found patients who received a cholesterol-lowering combination of ezetimibe/simvastatin experienced fewer major cardiovascular events than those taking simvastatin alone.
A new study presented today at American Heart Association’s Scientific Sessions suggests clinicians may have more evidenced-based options when considering preventative therapy for high-risk acute coronary syndrome patients.
Adding another type of cholesterol-lowering drug to statin therapy can better prevent heart attacks and strokes in high-risk patients with acute coronary syndrome.
Latest Issues
$auto_registration$